HealthEquity, Inc. (NASDAQ:HQY) Q3 2023 Earnings Conference Call December 6, 2022 4:30 PM ET

Company Participants

Richard Putnam - Investor Relations

Jon Kessler - President and Chief Executive Officer

Tyson Murdock - Executive Vice President and Chief Financial Officer

Stephen Neeleman - Founder and Vice Chairman

Conference Call Participants

Stephanie Davis - SVB Securities LLC

Anne Samuel - JPMorgan Chase & Co.

Gregory Peters - Raymond James & Associates, Inc.

Glen Santangelo - Jefferies LLC

Scott Schoenhaus - KeyBanc Capital Markets Inc.

Stanislav Berenshteyn - Wells Fargo Securities, LLC

Cynthia Motz - Goldman Sachs Group, Inc.

George Hill - Deutsche Bank AG

Mark Marcon - Robert W. Baird & Co.

Allen Lutz - Bank of America Merrill Lynch

Alexander Draper - Guggenheim Securities, LLC

Thomas Kelliher - RBC Capital Markets

David Larsen - BTIG

Operator

Good day, and welcome to the HealthEquity Third Quarter 2023 Earnings Conference Call. All participants will be in a listen-only mode. [Operator Instructions] After today's presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note this event is being recorded.

I would now like to turn the conference over to Richard Putnam. Please go ahead.

Richard Putnam

Thank you, Sarah. Happy holidays to everybody, and welcome to HealthEquity's third quarter fiscal year 2023 earnings conference call. My name is Richard Putnam. I do Investor Relations for HealthEquity. Joining me today is Jon Kessler, President and CEO; Dr. Steve Neeleman, Vice-Chair and Founder of the Company; and Tyson Murdock, the Company's Executive Vice President and CFO.

Before I turn the call over to Jon, I have two important reminders. First, a press release announcing our financial results for the third quarter of fiscal year 2023 was issued after the market closed this afternoon. The financial results in the press release include the contributions from our wholly-owned subsidiary, WageWorks and accounts it administers. The press release also includes definitions of certain non-GAAP financial measures that we will reference here today. A copy of today's press release, including reconciliations of these non-GAAP measures with comparable GAAP measures and a recording of this webcast can be found on our Investor Relations website, which is ir.healthequity.com.

Second, our comments and responses to your questions today reflect management's view as of today, December 6, 2022 and will contain forward-looking statements as defined by the SEC, including predictions, expectations, estimates, or other information that might be considered forward-looking. There are many important factors relating to our business, which could affect the forward-looking statements made today. These forward-looking statements are subject to risks and uncertainties that may cause the actual results to differ materially from the statements made here today.